Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001493152-25-010043·Aspire Biopharma Holdings, Inc.
Schedule 13G ownership disclosure
ASPIRE BIOPHARMA HLDGS INC
Common Stock · CUSIP: 738920107
Event date: 2025-03-03
- Filing-level shares
- 4,804,375.00
- Percent of class
- 9.825%
- Lance Friedman
Shares: 4,804,375.00 · Class: 9.825%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-010043
- Form type
- SCHEDULE 13G/A
- Filer
- Aspire Biopharma Holdings, Inc.
- CIK
- CIK 1847345
- Filed
- Mar 12, 2025
- Reporting period
- Mar 03, 2025
- Description
- Schedule 13G beneficial ownership